In Eμ‐Myc transgenic animals, lymphoma development requires the acquisition of additional genetic alterations, which commonly comprise of disruption of the p19ARF‐Mdm2‐p53 pathway or overexpression of Bcl2 34, 35. The gene discussed is MDM2; the disease is lymphoma.